JACKSONVILLE, Fla. — The Food and Drug Administration announced Monday it will remove long-standing “black box” warnings from hormone replacement therapy (HRT) drugs used by millions of women to manage menopause symptoms.

Health and Human Services Secretary Robert F. Kennedy Jr. confirmed the move, saying the warning labels, which previously cautioned about risks like stroke, heart attack, dementia and blood clots, are now considered outdated and unnecessary.

“The FDA is announcing today that it will remove the misleading black box warnings from all HRT products,” Kennedy said.

Medical experts say the move is a win for women nationwide.

Dr. Payal Kohli, a First Coast News medical consultant, explained the change reflects advances in science and an emphasis on personalized treatment.

See Full Page